New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization

Vaccinia virus (VACV) is a promising oncolytic agent because it exhibits many characteristic features of an oncolytic virus. However, its effectiveness is limited by the strong antiviral immune response induced by this virus. One possible approach to overcome this limitation is to develop deimmunize...

Descripción completa

Detalles Bibliográficos
Autores principales: Khlusevich, Yana, Matveev, Andrey, Emelyanova, Lyudmila, Goncharova, Elena, Golosova, Natalia, Pereverzev, Ivan, Tikunova, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227246/
https://www.ncbi.nlm.nih.gov/pubmed/35746695
http://dx.doi.org/10.3390/v14061224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227246/
https://www.ncbi.nlm.nih.gov/pubmed/35746695
http://dx.doi.org/10.3390/v14061224

Ejemplares similares